Norman Clayman Endocrine Institute — 1 certified H-1B filings (FY2024)

1
Filings · FY2024
$350k
Median base · FY2024
Thyroid Surgeon
Top role · 1 all-time
FL
Top state · 1 all-time
FY

Norman Clayman Endocrine Institute filed 1 certified H-1B LCAs in FY2024, with a median base salary of $350k and the middle 50% of offers between $350k and $350k. Across all years it has 1 certified filings since FY2024, most often for Thyroid Surgeon in Florida.

How much does Norman Clayman Endocrine Institute pay H-1B workers?

Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $350k median in FY2024. Base pay only — hover a year for its figures.

$340k$350k$360k’24

How has Norman Clayman Endocrine Institute's H-1B hiring changed by year?

1 certified filings on record (FY2024).

Norman Clayman Endocrine Institute certified H-1B filings and base salary by fiscal year
Fiscal yearFilingsvs prior FYMedian base
FY20241—$350k

What jobs does Norman Clayman Endocrine Institute sponsor for H-1B?

The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.

Norman Clayman Endocrine Institute most-sponsored H-1B job titles with base-salary percentiles
Job titleFilingsMedian base
Thyroid Surgeon1$350k

Where does Norman Clayman Endocrine Institute hire H-1B workers?

Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.

11Certified filings (log scale)
Norman Clayman Endocrine Institute H-1B worksite states
StateFilingsMedian base
FL1$350k

What has Norman Clayman Endocrine Institute filed recently?

Every certified LCA on record for Norman Clayman Endocrine Institute: job title, worksite, prevailing-wage level and the offered base salary.

Norman Clayman Endocrine Institute recent certified H-1B LCA filings
FYJob titleBase salary
2024Thyroid Surgeon$350,000

Common questions about Norman Clayman Endocrine Institute's H-1B filings

How much does Norman Clayman Endocrine Institute pay H-1B workers?
Norman Clayman Endocrine Institute's median certified H-1B base salary is $350k (FY2024), from 1 filings. See the full salary distribution and percentiles above.
How many H-1B workers does Norman Clayman Endocrine Institute sponsor?
Norman Clayman Endocrine Institute has 1 certified H-1B Labor Condition Applications on record (FY2024).
What jobs does Norman Clayman Endocrine Institute sponsor for H-1B?
Norman Clayman Endocrine Institute's most-sponsored H-1B roles include Thyroid Surgeon.
Where does Norman Clayman Endocrine Institute hire H-1B workers?
Norman Clayman Endocrine Institute's top H-1B worksite states are FL.
Does a certified LCA mean an H-1B visa was approved?
No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
What salary do these figures show?
The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
What do prevailing-wage levels I–IV mean?
The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.

Keep exploring

Browse all sponsors →

Calculate your H-1B lottery odds →orCheck out the insights →

Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2024). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →